Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Entero Therapeutics (ENTO) has provided an announcement.
Entero Therapeutics, Inc. has announced through a press release by CEO James Sapirstein a letter to its shareholders. The communication, which is not considered filed under SEC regulations, provides updates without becoming part of the company’s formal SEC filings. This move aims to keep shareholders informed without adding to the company’s legal filings.
See more insights into ENTO stock on TipRanks’ Stock Analysis page.
